FLT1 and neoplasm: Moreover, while FLT1 blockade with PARPi treatment is accompanied by increased CD8+ T-cell infiltration and tumor regression in immunocompetent mice, these effects were absent in T-cell-deficient nude-Foxn1nu mice.